1-3 of 3
Jan Cools, Ph.D.
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

MYB Overexpression Is Directly Involved in Acute Myeloid Leukemia Pathogenesis and Could Constitute a New Therapeutic Target for Patients with Aberrant Expression of This Gene.

Carmen Vicente, Ph.D., Ana Conchillo, Ph.D., Daphnie Pauwels, BSc, Iria Vazquez, Ph.D., Laura Garcia-Orti, BSc, Maria J. Calasanz, Ph.D., Idoya Lahortiga, Ph.D., Jan Cools, Ph.D., Maria D. Odero, MD, Ph.D.
Journal: Blood
Blood (2009) 114 (22): 2402.
https://doi.org/10.1182/blood.V114.22.2402.2402
Published: 2009
Journal Articles

Evaluation of the Role of PlGF and the Therapeutic Potential of Anti-PlGF in BCR/ABL+ Leukemia.

Sonja Loges, M.D., Ph.D, Thomas Schmidt, M.D., Maria Kleppe, Kim De Keersmaecker, Ph.D., Marc Tjwa, M.D., Ph.D., Christa Maes, Ph.D., Christiane DeWolf-Peeters, M.D., Ph.D., Geert Carmeliet, M.D., Ph.D., Jan Cools, Ph.D., Jean-Marie Stassen, Ph.D., Peter Carmeliet, M.D., Ph.D.
Journal: Blood
Blood (2008) 112 (11): 1094.
https://doi.org/10.1182/blood.V112.11.1094.1094
Published: 2008
Journal Articles

Mechanisms of Activation of the FIP1L1-PDGFRα Fusion Kinase.

Elizabeth H. Stover, B.A., Jan Cools, Ph.D, D. Gary Gilliland, Ph.D, M.D.
Journal: Blood
Blood (2004) 104 (11): 2422.
https://doi.org/10.1182/blood.V104.11.2422.2422
Published: 2004